Publications:

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm.

Blood Cancer Journal

Künstner, Axel A; Schwarting, Julian J; Witte, Hanno M HM; Bernard, Veronica V; Stölting, Stephanie S; Kusch, Kathrin K; Nagarathinam, Kumar K; von Bubnoff, Nikolas N; Murga Penas, Eva Maria EM; Merz, Hartmut H; Busch, Hauke H; Feller, Alfred C AC; Gebauer, Niklas N

Publication Date: 2022-07-04

Variant appearance in text: ERBB2: A1076T

PubMed Link: 35788129

Variant Present in the following documents:

• 41408_2022_699_MOESM3_ESM.xlsx, sheet 1

View BVdb publication page

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Npj Breast Cancer

Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F

Publication Date: 2020

Variant appearance in text: HER2: A1076T

PubMed Link: 33145402

Variant Present in the following documents:

• 41523_2020_201_MOESM1_ESM.pdf

View BVdb publication page

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial.

Ebiomedicine

Zhang, Yi-Chen YC; Chen, Zhi-Hong ZH; Zhang, Xu-Chao XC; Xu, Chong-Rui CR; Yan, Hong-Hong HH; Xie, Zhi Z; Chuai, Shao-Kun SK; Ye, Jun-Yi JY; Han-Zhang, Han H; Zhang, Zhou Z; Bai, Xiao-Yan XY; Su, Jian J; Gan, Bin B; Yang, Jin-Ji JJ; Li, Wen-Feng WF; Tang, Wei W; Luo, Feng Roger FR; Xu, Xiao X; Wu, Yi-Long YL; Zhou, Qing Q

Publication Date: 2019-05

Variant appearance in text: ERBB2: 3226G>A; Ala1076Thr

PubMed Link: 31027916

Variant Present in the following documents:

• mmc3.xlsx, sheet 1

View BVdb publication page